(ShareCast News) - Stocks in London were continuing to move higher come midday on Monday, alongside the largest gain the pound in three months, with investors taking their cue from strong gains in Asia as Brexit polls showed the Remain campaign was in the lead. As of 12:03 BST, the FTSE 100 was 183.
Read more(ShareCast News) - Stocks in London surged at the start of trading, alongside the largest gain the pound in three months, with investors taking their cue from strong gains in Asia as Brexit polls showed the Remain campaign was in the lead. As of 08:43 BST the FTSE 100 was 145.82 points or 2.42% high
Read more(ShareCast News) - Shares in biopharmaceutical development company Circassia Pharmaceuticals plummeted on Monday morning, after it announced disappointing top-line results from its investigational cat allergy immunotherapy phase III study. At 0815 BST, shares in Circassia were down 55.86% at 119.3p.
Read more(ShareCast News) - Circassia Pharmaceuticals kicked off phase-three trials for its grass allergy treatment, the second imunotherapy programme for which it was seeking regulatory approval, and said it was on-track to report the results of its phase-three clinical trials for its Cat allergy treatment
Read more(ShareCast News) - Circassia Pharmaceuticals became a revenue-making business in 2015, and was making firm progress on a number of its products under development, it reported in its preliminary results on Friday. The FTSE 250 company published robust revenue growth through the calendar year through
Read more